Joinn Laboratories (China) Co (HKSE:06127) Accounts Payable & Accrued Expense : HK$251 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Joinn Laboratories (China) Co Accounts Payable & Accrued Expense?

Joinn Laboratories (China) Co's quarterly accounts payable & accrued expense increased from Sep. 2023 (HK$304 Mil) to Dec. 2023 (HK$310 Mil) but then declined from Dec. 2023 (HK$310 Mil) to Mar. 2024 (HK$251 Mil).

Joinn Laboratories (China) Co's annual accounts payable & accrued expense increased from Dec. 2021 (HK$257 Mil) to Dec. 2022 (HK$576 Mil) but then declined from Dec. 2022 (HK$576 Mil) to Dec. 2023 (HK$310 Mil).

Joinn Laboratories (China) Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Joinn Laboratories (China) Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Joinn Laboratories (China) Co Accounts Payable & Accrued Expense Chart

Joinn Laboratories (China) Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

144.44

199.54

257.25

575.61

310.09

Joinn Laboratories (China) Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															405.25	519.19	303.87	310.09	251.29

Joinn Laboratories (China) Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Joinn Laboratories (China) Co (HKSE:06127) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Joinn Laboratories (China) Co Ltd (HKSE:06127) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

603127:China

Address

A5 Rongjing East Street, Beijing Economic-Technological Development Area, Beijing, CHN, 100176

Website

https://www.joinnlabs.com

Joinn Laboratories (China) Co Ltd is a non-clinical contract research organization(CRO) focused on drug safety assessment. It operates in three segments: Non-clinical studies services include drug safety assessment, drug metabolism & pharmacokinetics (DMPK) studies, & pharmacology & efficacy studies; Clinical trial & related services segment provides early-stage services such as clinical CRO services, co-managed phase I clinical research units, & bioanalytical services, and: Sales of research models engages in the design, production, breeding, & sales of research models, currently including non-human primates and rodents. The majority is from the Non- Clinical studies services. Its geographical segments are China, the United States, and Other countries, of which the majority is from China.

Joinn Laboratories (China) Co (HKSE:06127) Headlines

No Headlines